Caffeine is the most widely consumed psychoactive substance. Whereas the use of alcohol and tobacco are usually limited during pregnancy, beverages containing caffeine are consumed at a normal or near normal rate (1) . Negative effects on fertility and birthweight, risk for prematurity, and congenital malformations have been demonstrated in offspring of animals given high doses of caffeine (for review see Ref. 2 ), but there is no conclusive evidence that normal human consumption has teratological consequences. Epidemiologic studies have shown a dose-dependent reduction in birth weight when mothers consume more than seven cups of coffee a day (3, 4) . Prenatal caffeine intake has been described to result in behavioral hyperactivity in developing rodents (5-7).
The only known biochemical effect of caffeine in the brain in concentrations relevant to daily intake of coffee is blockade of adenosine A 1 and A 2A receptors (8) . Both A 1 and A 2A receptors are present at birth in the rat (9 -11), but the major development in terms of density and coupling to second messenger-forming systems occurs postnatally (12, 13) . Secondarily to actions on adenosine receptors there are effects on dopaminergic transmission (for review see Ref. 14, 15) and it is known that alterations in dopaminergic transmission may result in developmental changes (16) . In addition, there is evidence that caffeine can directly and indirectly influence GABAergic neurotransmission (8, 15) . Studies on the effects of methylxanthines on benzodiazepine receptors are contradictory. An increased number of benzodiazepine binding sites in the adult mouse brain after chronic administration of a high dose of caffeine has been reported (17, 18) , but other investigators have shown no change at all (19, 20) or altered function of the receptor (21) .
Caffeine given in doses similar to those resulting in longterm behavioral changes has been reported to alter the postnatal (32) . The adenosine receptor probes have been tested for specificity (33, 34) . The oligodeoxyribonucleotides were radiolabeled using terminal deoxyribonucleotidyl transferase and [
35 S] dATP to a specific activity of about 10 9 cpm/g. Slide-mounted sections were hybridized in a cocktail containing 50% formamide, 4ϫSSC, 1ϫDenhardt's solution, 1% sarcosyl, 0.02 M NaPO 4 (pH 7.0), 10% dextran sulfate, 0.06 M dithiotreitol, 0.5 mg/mL sheared salmon sperm DNA, and 10 7 cpm/mL of probe. After hybridization for 15 h at 42°, the sections were washed four times, 15 min, in 1ϫSSC at 55°(A 1 probe) or 45°(A 2A probe), then dipped briefly in water and 70%, 95%, and 99.5% ethanol, and air-dried. Finally, the sections were apposed to Hyperfilm ␤-max for 1-4 wk.
Drugs and chemicals. Image analysis. Analysis of receptor expression and binding was performed using a computerized image analysis system (Imaging Research Systems, St Catherines, Ontario, Canada). Relative optic density of expression or binding was measured in autoradiograms and amounts of receptor-bound radioactivity of the specific brain regions were determined using [
3 H] microscale standards. Specific binding was calculated by subtraction of the OD values in sections where nonspecific binding was determined. Different regions of the brain in the prenatal rats were identified using the atlas by Altman and Bayer (35) and in postnatal rats using atlases by Sherwood and Timiras (36) and Paxinos and Watson (37) .
Statistics. Results are given as mean ϮSEM. Weight and fecundity were compared between the groups using the t test. Water intake was compared between caffeine and control group using the t test and multivariate ANOVA, repeated measures design with Scheffe's F post hoc test using procedures in the JMP statistics package by SAS (Cary, NC, U.S.A.). The results from quantitative receptor autoradiography and in situ hybridization in each specific brain region were analyzed by two-way ANOVA (Graph Pad Prism; SYSTAT). All measurements were done on sections from 5 or 6 animals and each brain was treated as one observation by averaging density values of each region studied. Statistical hypotheses were considered significant if p Ͻ 0.05.
RESULTS
Caffeine ingestion did not alter weight gain during first week of pregnancy (20.5 Ϯ 0.9% in caffeine treated group and 19.0 Ϯ 0.9% in controls), fecundity (10.88 Ϯ 0.55 pups and 10.91 Ϯ 0.59 pups, respectively) or birth weight (6.0 Ϯ 0.31 g and 5.5 Ϯ 0.22 g, respectively). Litters that received caffeine drank more than control litters at all postnatal time points studied (p Ͻ 0.05), but differences were small (1-8 mL per litter per day). The increased water intake in the caffeine group might be explained by the diuretic actions of xanthine adenosine antagonists (38) . Plasma concentrations of caffeine and the metabolites theophylline, paraxanthine, and theobromine were measured on P7 and are presented in Table 1 .
Adenosine A 1 Receptor mRNA and [ 3 H]-DPCPX Binding
We found that adenosine A 1 receptor mRNA was present on E14 in low levels in the neuroepithelium, in agreement with previous studies (9, 11 (Fig. 1) . On E21, the distribution of A 1 mRNA, and DPCPX binding resembled that seen in the adult rat brain, but levels were lower ( Figs. 1 and 2 ). There were no differences in adenosine receptors in the brains of pups decapitated shortly after vaginal delivery (2 or 24 h) compared with levels on E21 (Fig. 2) .
In the cerebral cortex, both A 1 receptor mRNA and [ 3 H]-DPCPX binding were detected on E18. Whereas mRNA levels were 40% of levels on P21, only a small amount of receptor protein was detected (8% of levels on P21). There was a clear elevation of both mRNA and receptor protein levels between P3 and P7 (Fig. 2) . Caffeine-treated fetuses were found to have the same levels of both mRNA and receptor protein as controls. However at 24 h (P24h) and 7 d after birth (P7), [ 3 H]-DPCPX binding was significantly higher in caffeine-exposed pups than in controls (31%, p ϭ 0.044 and 15%, p ϭ 0.033, respectively). A 1 mRNA in caffeine group was not altered at any time point studied compared with controls.
In cerebellar cortex, the development of A 1 receptors was clearly delayed compared with other regions. Both A 1 mRNA ) and low-dose caffeine-treated (black bars) rat fetuses (1 ϭ E14, 2 ϭ E18, 3 ϭ E21) and pups (4 ϭ P2h, 5 ϭ P24h, 6 ϭ P3, 7 ϭ P7, 8 ϭ P14, and 9 ϭ P21). In cortex, measurements include all cortex layers; hippocampal measurements include CA1, CA3, and dentate gyrus. Measurements on E14 were not performed in each region, but represent a "whole brain" value. Mean and SEM of groups with n ϭ 6. * represents a p value Ͻ 0.05 when comparing controls and caffeine-treated pups. In all regions there was a highly significant (p Ͻ 0.001) age-related change for A 1 (Fig. 2) . Receptor protein increased earliest in this region, and on P7, the distribution of A 1 mRNA and [
3 H]-DPCPX binding in the hippocampus was qualitatively the same as in the oldest animals studied here. There were no statistically significant differences in [ 3 H]-DPCPX binding, but A 1 mRNA levels were slightly lower in the caffeine-treated animals than in controls. A significant difference was observed if the data on P3-P21 were pooled (6% to 12%, p ϭ 0.009).
Total A 1 mRNA amounts in thalamus reached adult levels already on E18, but the development of receptor binding had a time course similar to that in most A 1 receptor-rich areas. No differences were seen between the caffeine-treated animals and controls. (Fig. 3) in low amounts and binding with both ligands increased mainly between P3 and P14 (Fig. 4) . A 2A mRNA and receptor protein were also found in the olfactory tubercle (Fig. 3) , but no measurements were made there.
Whereas previous studies on the effect of low doses of caffeine have not indicated any clear-cut effects on A 1 receptors, recent results do show a decrease in A 2A receptors and the corresponding mRNA, which is related to the known behavioral tolerance (40) . There was no significant difference in development of A 2A mRNA or receptor binding between pups subjected to caffeine treatment and controls, and there were no differences in adenosine A 2A receptors shortly after birth.
GABA A Receptor Binding
The GABA A receptor ontogeny in different brain regions was studied using 
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cortex, hippocampus, and olfactory bulb was detected on E18 and in striatum on E21. There were no significant differences between controls and caffeine-treated animals at any specific time point or in any region.
DISCUSSION
The major finding of this study is that administration of caffeine in doses that resemble those consumed by humans does not significantly influence the development of receptors that are known or believed to be affected by this drug. These results are in apparent contrast to several previous studies mentioned at the beginning of this article, where caffeine has been reported to modify adenosine receptors and/or behavior.
A possible explanation is the difference in doses. For example, in neonatal pups who received 80 mg/kg/d of caffeine, behavioral effects were observed (7). This dose is some 10 -20 times higher than that ingested by the pups in the present study, who received the caffeine via the breast milk. In another study behavioral effects were observed in the offspring when mouse dams received more than 80 mg/kg/d during pregnancy (6) . In the present study the dose of caffeine given was low. It gives plasma concentrations in rat pups comparable to those seen in the umbilical cord plasma in newborns of moderately (up to 3 cups a day) coffee-drinking human mothers (0.5-2 mg/L) (42) . The plasma levels of the pups also resembled the concentrations in breast-fed infants of caffeine-consuming mothers (43, 44) .
Perinatal treatment with 6-to 12-fold higher doses of caffeine than those used here induces up-regulation of A 1 receptors in the postnatal and adult (P14 -90) rat brain (19, 22, 23, 45) . However, with the more relevant dosage used here little or no change in A 1 receptors was seen. We cannot exclude the possibility that there are some changes in some regions, but we can conclude that if they occur, they are small. In adult rodents there is good evidence that high doses of caffeine do produce increases in A 1 receptors, that are not accompanied by changes in A 1 receptor mRNA (33) . When lower doses are given no changes are observed, however. The present data considered together with the results of previous studies hence suggest that adaptive changes in adenosine A 1 receptors are strongly dependent on the dose of caffeine given, not only in adults but also in young animals.
Thus, some of the reported long-term adaptive changes in behavior or in adenosine receptors may represent a high dose phenomenon. It is well known that the behavioral effects of caffeine, at least in mature animals, are biphasic: low doses are behaviorally stimulant, whereas higher doses produce an inhibited motor behavior (see Ref. 8) . When caffeine is given in a low dose, it is unlikely that other receptors than adenosine A 1 and A 2A receptors are directly affected (8) . By contrast, higher doses can affect other targets including phosphodiesterases and benzodiazepine receptors.
The present results have confirmed that the primary targets for low-dose caffeine, i.e. the adenosine A 1 and A 2A receptors, are poorly developed in the immature rat brain. Beautiful studies on the prenatal development of mRNA of these receptors have already been published (9 -11) ; however, the postnatal development of mRNA has not been studied in detail before. Both the absolute magnitude of the binding and the magnitude of the postnatal increase agree with a previous study on rat forebrain (24) . Although A 1 mRNA was present already on E14, and A 1 receptor binding was apparent on E18 in agreement with previous studies (9, 10) , the number of A 1 receptors is almost 10 times lower at birth than in the mature animal. Moreover, part of the binding detected at the earliest times might represent A 2B receptors, because DPCPX has a high affinity also to these receptors (46) . The development of A 2A receptors has also been described (10, 12, 47) (30) .
Although A 1 and A 2A receptors are present at birth in the rat (9 -11), the major development in terms of density and coupling to second messenger-forming systems occurs postnatally (12, 13) . This is highlighted in a difference between the present data and those of Rivkees in the magnitude of the increase in A 1 receptors from birth to adulthood. Whereas we found a 5-to 10-fold increase, Rivkees et al. reported a doubling (9) . This might be explained by the fact that in the previous study GTP was not added to the binding assay and that, therefore, mainly A 1 receptors not coupled to G-proteins were detected. In our study, where GTP was added, both coupled and uncoupled receptors are detected, and in adult animals at least twice as many receptors are detected in the presence of GTP. This therefore suggests that in the immature brain few A 1 receptors are coupled to G proteins. Furthermore, we have other results using GTP␥S binding indicating that the A 1 receptors that are present are poorly coupled to G proteins (Ådén U, unpublished observation).
Therefore, we believe that a reason for a lack of major effect on, for example, adenosine receptors in the brain of animals receiving low doses of caffeine pre-and postnatally is that the primary targets for caffeine action are poorly developed both in number and in coupling to effector proteins. It must be borne in mind that the situation may be different in tissues outside the brain. Indeed, there is evidence that the cardiac adenosine A 1 receptors, for example, are well developed at birth (9) . It is possible that maternal caffeine intake may affect other tissues than those studied here. It is also conceivable that effects on tissues outside the CNS may influence brain development.
The changes in benzodiazepine binding sites during early development were much less pronounced than in the case of the adenosine receptors. No significant up-regulation of [results. Again these may be related to the dose of caffeine inasmuch as direct effects of caffeine on benzodiazepine receptors require 40 -100 times higher plasma concentrations than those observed here (see Ref. 8 for references). They are also higher than those measured in adults after normal human daily consumption of caffeine-containing beverages. Nonetheless, benzodiazepine receptors may be a target for high dose caffeine given perinatally.
In summary, the present results indicate that perinatal treatment with caffeine in doses that correspond to human consumption produces minimal changes in A 1 , A 2A , and GABA A receptors in cortex, hippocampus, striatum, and cerebellum. Although this is a negative finding it is potentially important because adaptive changes in these receptors have been linked to changes in the behavior of the offspring of coffee-consuming mothers. It is also suggested that the reason for the lack of effect is that in the immature brain the primary targets for caffeine given in low doses are poorly developed. Whereas the previous studies have raised concerns about maternal caffeine consumption, the present results may be reassuring for pregnant and breast-feeding human mothers who drink coffee in moderation.
